6,6-Dimethyl-3-azabicyclo[3.1.0]hexane CAS 943516-54-9 PF-07321332 Boceprevir Intermedia Featured Image

6,6-Dimethyl-3-azabicyclo[3.1.0]hexane CAS 943516-54-9 PF-07321332 Boceprevir Intermediatus

Description:

Nomen chemicum: 6,6-Dimethyl-3-azabicyclo[3.1.0]hexane

CAS: 943516-54-9

Aspectus: Hyalina Transparens Liquid

Puritas: ≥98.0%

Intermedium PF-07321332 Paxlovid (CAS 2628280-40-8) et Boceprevir (CAS 394730-60-0);

High Quality, Commercial Production

Inquiry: alvin@ruifuchem.com

Mitte ad nos inscriptio

Product Detail

Product Tags

Descriptio:

Commercial Supple PF-07321332 Paxlovid Intermedia cum High Quality
L-tert-Leucine (H-Tle-OH) CAS 20859-02-3
Caronic Anhydride CAS 67911-21-1
(1R,2S,5S)-6,6-Dimethyl-3-azabicyclo[3.1.0]hexane-2-Carboxylic Acid Methyl Ester Hydrochloride 565456-77-1
Methyl(S)-2-(Boc-amino)-3-[(S)-2-oxo-3-pyrrolidinyl]propanoate CAS 328086-60-8
6,6-Dimethyl-3-azabicyclo[3.1.0]hexane CAS 943516-54-9

Chemical Properties:

Nomen chemicum	6,6-Dimethyl-3-azabicyclo[3.1.0]hexane
CAS Number	943516-54-9
CATTUS Number	RF-PI316
Stock Status	In Stock, Productio Ascendite ad Tons
Formulae hypotheticae	C7H13N
M. Pondus	111.18
Ferveret	135℃
Density	0.911
Brand	Ruifu Chemical

Specifications:

Item	Specifications
Aspectus	Hyalina Transparens Liquid
Puritas	≥98.0%
una immunditia	≤0.50%
Totalis immunditias	≤2.0%
Metalla gravis	≤20ppm
Test Standard	Enterprise Standard
Consuetudinem	Intermedium PF-07321332 Paxlovid (CAS 2628280-40-8) et Boceprevir (CAS 394730-60-0);

Sarcina & Repono:

sarcina: Utrem, aluminium foil, pera, cardboard tympanum, 25kg/Drum, vel secundum exigentiam emptoris.

Repono Condition:Repone in vasis signatis in loco frigido et sicco;Protege a lumine, humore et pestis infestatione.

commoda:

FAQ:

Applicatio:

6,6-Dimethyl-3-azabicyclo[3.1.0] hexane (CAS 943516-54-9) est medium PF-07321332 Paxlovid (CAS 2628280-40-8) et Boceprevir (CAS 394730-60-0).Pfizer's Paxlovid PF-07321332 est oralis antiviralis therapeuticae nisi SARS-CoV-2 betacoronavirus ad impediendum COVID-19.Paxlovid inhibitor protease est qui potentem in vitro antivirali actione contra SARS-CoV-2 et alios coronaviros demonstravit, potentialem usum in tractatione COVID-19 significans, ac etiam potentialem usum contra minis virus futurum, dicit Pfizer.Boceprevir (EBP 520) potens est, valde selectiva, oretenus bioavailable HCV NS3 inhibitoris protease cum a Ki 14 nM in utroque enzyme primordium et ec90 350 nM in cella replicon-nitentem tentare.Boceprevir nia Sars-CoV 2 3CLpro actione.